Melissa Hollo: Improving Pregnancy Outcomes in Pulmonary Arterial Hypertension
Melissa Hollo, Licensed Independent Clinical Social Worker, Director of Project Management at hc1, shared a post on LinkedIn about a recent article by Li Mu et al, published in European Journal of Obstetrics and Gynecology and Reproductive Biology, adding:
“Maternal health technology is making significant strides, benefiting both mothers and their babies.
A recent study published in the European Journal of Obstetrics and Gynecology and Reproductive Biology highlights that elevated SPP1 levels may help identify pregnant women with pulmonary arterial hypertension (PAH) who are at an increased risk for serious postpartum complications.
The research is compelling, and the next step is to integrate these advancements into routine clinical care.
Solutions like hc1 Clinical IQ HerCare assist health systems in operationalizing emerging evidence by:
- Identifying patients who may benefit from additional testing
- Supporting standardized care pathways
- Enabling earlier intervention
Earlier identification paves the way for better proactive care, steering maternal healthcare in a positive direction.
Learn how we’re supporting earlier maternal risk detection.”
Title: SPP1 improves early risk assessment of postpartum adverse events in pulmonary arterial hypertension complicated with pregnancy
Authors: Li Mu, Hui Yuan, Jun Zhang, Junyi Wu, Haofeng Zhang, Jiashu Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy